Harrow Financial Statements From 2010 to 2025

HROWL Stock  USD 25.32  0.02  0.08%   
Harrow Health financial statements provide useful quarterly and yearly information to potential Harrow Health 8625 investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Harrow Health financial statements helps investors assess Harrow Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Harrow Health's valuation are summarized below:
Market Capitalization
247.5 M
There are over one hundred nineteen available fundamental trends for Harrow Health 8625, which can be analyzed over time and compared to other ratios. We recommend to confirm Harrow Health's regular fundamental drivers against the all of the trends between 2010 and 2025. Market Cap is expected to rise to about 345.2 M this year. Enterprise Value is expected to rise to about 455.2 M this year

Harrow Health Total Revenue

157.21 Million

Check Harrow Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health's main balance sheet or income statement drivers, such as Interest Expense of 25.7 M, Selling General Administrative of 70.3 M or Selling And Marketing Expenses of 5.2 M, as well as many indicators such as Price To Sales Ratio of 3.07, Dividend Yield of 6.0E-4 or PTB Ratio of 11.43. Harrow financial statements analysis is a perfect complement when working with Harrow Health Valuation or Volatility modules.
  
Check out the analysis of Harrow Health Correlation against competitors.
For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.

Harrow Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets376.9 M359 M98.2 M
Slightly volatile
Total Current Liabilities59.6 M56.7 M15.8 M
Slightly volatile
Cash89.5 M85.2 M28.3 M
Slightly volatile
Cash And Short Term Investments99.9 M95.2 M35.3 M
Slightly volatile
Common Stock Shares Outstanding39.4 M37.5 M19.1 M
Slightly volatile
Liabilities And Stockholders Equity376.9 M359 M98.2 M
Slightly volatile
Other Stockholder Equity247.1 M235.3 M101.4 M
Slightly volatile
Total Liabilities291.9 M278 M73.7 M
Slightly volatile
Total Current Assets168.4 M160.4 M51.4 M
Slightly volatile
Common Stock42.3 K40.2 K21.4 K
Slightly volatile
Accounts Payable25.9 M24.6 M7.9 M
Slightly volatile
Non Current Liabilities Total232.3 M221.3 M57.9 M
Slightly volatile
Other Current Assets11.3 M10.8 M3.8 M
Slightly volatile
Property Plant And Equipment Net12.4 M11.9 M6.3 M
Slightly volatile
Non Current Assets Total208.5 M198.6 M46.8 M
Slightly volatile
Short and Long Term Debt Total230 M219.1 M57.6 M
Slightly volatile
Current Deferred Revenue71.3 K86.2 K59.6 K
Slightly volatile
Short Term Debt880.6 K926.9 K1.4 M
Pretty Stable
Net Receivables44.1 M42 M9.2 M
Slightly volatile
Good Will283.9 K298.8 K815.5 K
Pretty Stable
Short Term Investments10.8 M10 M7.5 M
Slightly volatile
Inventory13.1 M12.5 MM
Slightly volatile
Intangible Assets195.7 M186.4 M37.9 M
Slightly volatile
Long Term Debt125.8 M119.8 M39.5 M
Slightly volatile
Capital Surpluse113.7 M157.6 M102 M
Slightly volatile
Property Plant Equipment5.7 M3.1 M6.6 M
Slightly volatile
Common Stock Total Equity20.9 K34.5 K8.9 K
Slightly volatile
Long Term Debt Total69 M119.8 M37.8 M
Slightly volatile
Long Term Investments8.2 M12.8 MM
Slightly volatile
Property Plant And Equipment GrossK10.1 K11 K
Slightly volatile
Non Current Liabilities Other5.6 M6.6 M7.2 M
Slightly volatile
Other Assets1.3 M1.4 M1.6 M
Slightly volatile

Harrow Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense25.7 M24.5 M6.4 M
Slightly volatile
Selling General Administrative70.3 M67 M29.3 M
Slightly volatile
Selling And Marketing Expenses5.2 M8.1 M5.4 M
Slightly volatile
Other Operating Expenses156.7 M149.2 M54.1 M
Slightly volatile
Research DevelopmentM7.6 M2.9 M
Slightly volatile
Total Operating Expenses108.8 M103.6 M38.2 M
Slightly volatile
Depreciation And Amortization14.9 M14.2 M3.7 M
Slightly volatile
Total Revenue157.2 M149.7 M49.9 M
Slightly volatile
Gross Profit109.3 M104.1 M34 M
Slightly volatile
Cost Of Revenue47.9 M45.6 M16.2 M
Slightly volatile
Interest Income7.9 M4.3 M4.8 M
Pretty Stable
Non Recurring244.8 K224.1 K325.6 K
Slightly volatile
Preferred Stock And Other Adjustments377.6 K424.8 K463.1 K
Slightly volatile

Harrow Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow116.2 M110.7 M27.5 M
Slightly volatile
End Period Cash Flow89.5 M85.2 M28.3 M
Slightly volatile
Stock Based Compensation19 M18.1 M5.8 M
Slightly volatile
Depreciation14.9 M14.2 M3.7 M
Slightly volatile
Dividends Paid749 K788.4 K1.1 M
Very volatile
Net Borrowings66.5 M63.4 M19.5 M
Slightly volatile
Cash Flows Other OperatingM2.2 M3.1 M
Pretty Stable
Change To Netincome7.7 M12.6 M5.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.073.23269
Slightly volatile
Dividend Yield6.0E-46.0E-40.0013
Slightly volatile
Days Sales Outstanding96.6792.0736.7625
Slightly volatile
Stock Based Compensation To Revenue0.130.1423.8212
Slightly volatile
Capex To Depreciation11.6811.134.9774
Slightly volatile
EV To Sales4.044.26153
Slightly volatile
Inventory Turnover5.234.194.2932
Slightly volatile
Days Of Inventory On Hand92.8111596.846
Slightly volatile
Payables Turnover2.241.672.344
Slightly volatile
Sales General And Administrative To Revenue0.730.77148
Slightly volatile
Average Inventory431.5 K803.1 K637.4 K
Slightly volatile
Research And Ddevelopement To Revenue0.05580.058812.5785
Slightly volatile
Capex To Revenue1.411.350.4757
Slightly volatile
Cash Per Share3.292.921.5449
Slightly volatile
Days Payables Outstanding170227184
Slightly volatile
Intangibles To Total Assets0.490.470.2047
Slightly volatile
Current Ratio5.93.255.6517
Slightly volatile
Receivables Turnover3.94.115.2081
Slightly volatile
Capex Per Share4.424.210.9771
Slightly volatile
Revenue Per Share3.773.591.6938
Slightly volatile
Debt To Assets0.670.71.1338
Slightly volatile
Graham Number3.033.413.7187
Slightly volatile
Operating Cycle93.73182126
Very volatile
Days Of Payables Outstanding170227184
Slightly volatile
Long Term Debt To Capitalization0.790.834.5913
Slightly volatile
Quick Ratio5.723.05.4453
Slightly volatile
Net Income Per E B T0.880.933.3936
Very volatile
Cash Ratio1.641.734.3305
Slightly volatile
Days Of Inventory Outstanding92.8111596.846
Slightly volatile
Days Of Sales Outstanding96.6792.0736.7625
Slightly volatile
Fixed Asset Turnover11.9411.376.8064
Slightly volatile
Debt Ratio0.670.71.1338
Slightly volatile
Price Sales Ratio3.073.23269
Slightly volatile
Asset Turnover0.460.380.4901
Slightly volatile
Gross Profit Margin0.470.630.5257
Slightly volatile

Harrow Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap345.2 M328.8 M154.3 M
Slightly volatile
Enterprise Value455.2 M433.6 M180.2 M
Slightly volatile

Harrow Fundamental Market Drivers

Cash And Short Term Investments82.8 M

About Harrow Health Financial Statements

Harrow Health investors utilize fundamental indicators, such as revenue or net income, to predict how Harrow Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue86.2 K71.3 K
Total Revenue149.7 M157.2 M
Cost Of Revenue45.6 M47.9 M
Stock Based Compensation To Revenue 0.14  0.13 
Sales General And Administrative To Revenue 0.77  0.73 
Research And Ddevelopement To Revenue 0.06  0.06 
Capex To Revenue 1.35  1.41 
Revenue Per Share 3.59  3.77 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Harrow Health 8625 is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:
Check out the analysis of Harrow Health Correlation against competitors.
For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Equity
0.4484
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.